Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth

Vaccine

Volumn 26, Issue 5, 2008, Pages 647-652

  Carniel, E F ^a   Morcillo, A M ^a   Blotta, M H ^a   Da Silva, M T N ^a   Mazzola, T N ^a   Antonio, M A R G M ^a   Zanolli, M L ^a   Netto, A Aranha ^a   Higashi, H G ^b   Raw, I ^b   Vilela, M M S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Combined vaccines; Hepatitis B vaccines; Humoral immunity

Indexed keywords

BCG VACCINE; BUTANG; HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HEPATITIS B; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TUBERCULOSIS;

BCG VACCINE; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION SCHEDULE; INFANT, NEWBORN; INJECTIONS, INTRADERMAL; MALE; PROSPECTIVE STUDIES; VACCINATION; VACCINES, COMBINED; VACCINES, SYNTHETIC;

EID: 37848999301     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.048     Document Type: Article

References (35)

1. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 18 (2000) S17-S19
2. Silveira T.R., da Fonseca J.C., Rivera L., Fay O.H., Tapia R., Santos J.L., et al. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica 6 6 (1999) 378-383
3. Hallauer J. VHPB: summary of strategies and recommendations. Vaccine 13 S1 (1995) S61-S63
4. Baldy J.L., de Lima G.Z., Morimoto H.K., Reiche E.M., Matsuo T., de Mattos E.D., et al. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination. Rev Inst Med Trop Sao Paulo 46 2 (2004) 103-107
5. Martins R.M., Bensabath G., Arraes L.C., Oliveira M., de L., Miguel J.C., et al. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B. Mem Inst Oswaldo Cruz 99 8 (2004) 865-871
6. Mahoney F.J., and Kane M. Hepatitis B vaccine. In: Plotkin A.S., and Orenstein W.A. (Eds). Vaccines (1999), WB Saunders, Philadelphia 158-182
7. Guidotti L.G., and Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19 (2001) 65-91
8. Honorati M.C., Dolzani P., Mariani E., Piacentini A., Lisignoli G., Ferrari C., et al. Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 112 6 (1997) 2017-2027
9. Böcher W.O., Herzog-Hauff S., Schlaak J., Meyer Zum Büschenfelde K.H., and Löhr H.F. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Hepatology 29 1 (1999) 238-244
10. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.H., and Siegrist C.A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 26 7 (1996) 1489-1496
11. Marchant A., Goetghebuer T., Ota M.O., Wolfe I., Ceesay S.J., De Groote D., et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol 163 4 (1999) 2249-2255
12. Vekemans J., Amedei A., Ota M.O., D'Elios M.M., Goetghebuer T., Ismaili J., et al. Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 31 5 (2001) 1531-1535
13. Ota M.O., Vekemans J., Schlegel-Haueter S.E., Fielding K., Sanneh M., Kidd M., et al. Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol 168 2 (2002) 919-925
14. Ota M.O., Vekemans J., Schlegel-Haueter S.E., Fielding K., Whittle H., Lambert P.H., et al. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine 22 3-4 (2004) 511-519
15. Blackwelder W.C. Similarity/equivalence trials for combination vaccines. Ann NY Acad Sci 754 (1995) 321-328
16. Röhmel J. Therapeutic equivalence investigations: statistical considerations. Stat Med 17 15-16 (1998) 1703-1714
17. Horne A.D., Lachenbruch P.A., Getson P.R., and Hsu H.S. Analysis of studies to evaluate immune response to combination vaccines. Clin Infect Dis 33 S4 (2001) S306-S311
18. Horne A.D. The statistical analysis of immunogenicity data in vaccine trials. Ann NY Acad Sci 754 (1995) 329-346
19. Gabutti G., Bona G., Dentico P., Bamfi F., Hardt K., Majori S., et al. Immunogenicity and reactogenicity following primary immunisation with a combined DTaP-HBV vaccine and a Haemophilus influenzae type b vaccine administered by separate or mixed injection. Clin Drug Investig 25 5 (2005) 315-323
20. Pichichero M.E., Bernstein H., Blatter M.M., Schuerman L., Cheuvart B., Holmes S.J., et al. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. J Pediatr 151 1 (2007) 43-49
21. Isolani A.P., Sversuti C.S., Sell A.M., and Moliterno R.A. Protection against hepatitis B by the Butang recombinant vaccine in newborn children in South Brazil. Mem Inst Oswaldo Cruz 101 5 (2006) 551-553
22. Elisbao M., do C., Baldy J.L., Bonametti A.M., Reiche E.M., Morimoto H.K., et al. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory. Mem Inst Oswaldo Cruz 98 8 (2003) 1109-1113
23. Francois G., Duclos P., Margolis H., Lavanchy D., Siegrist C.A., Meheus A., et al. Vaccine safety controversies and the future of vaccination programs. Pediatr Infect Dis J 24 11 (2005) 953-961
24. Martino A., Casetti R., and Poccia F. Enhancement of BCG-induced Th1 immune response through Vγ9Vδ2 T cell activation with non-peptidic drugs. Vaccine 25 6 (2007) 1023-1029
25. Girardi M. Immunosurveillance and immunoregulation by gammadelta T cells. J Invest Dermatol 126 1 (2006) 25-31
26. Shrestha N., Ida J.A., Lubinski A.S., Pallin M., Kaplan G., and Haslett P.A. Regulation of acquired immunity by gamma delta T-cell/dendritic-cell interactions. Ann NY Acad Sci 1062 (2005) 79-94
27. Larson A.A., and Dinulos J.G. Cutaneous bacterial infections in the newborn. Curr Opin Pediatr 17 (2005) 481-485
28. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7 5 (2007) 379-390
29. Adkins B., Leclerc C., and Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4 7 (2004) 553-564
30. Salmi M., and Jalkanen S. Lymphocyte homing to the gut: attraction, adhesion, and commitment. Immunol Rev 206 (2005) 100-113
31. Marchant A., and Goldman M. T cell-mediated immune responses in human newborns: ready to learn?. Clin Exp Immunol 141 1 (2005) 10-18
32. + T cell expansion in infants immunized at birth with BCG vaccine. Vaccine 25 34 (2007) 6313-6320
33. Kaplan G. Rational vaccine development-a new trend in tuberculosis control. N Engl J Med 353 15 (2005) 1624-1625
34. Foulds K.E., Wu C.Y., and Seder R.A. Th1 memory: implications for vaccine development. Immunol Rev 211 (2006) 58-66
35. Tovo P.A., Lazier L., and Versace A. Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 18 3 (2005) 261-266